Price (delayed)
$61.27
Market cap
$8.57B
P/E Ratio
120.14
Dividend/share
N/A
EPS
$0.51
Enterprise value
$8.75B
Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza , Tegsedi , and
There are no recent dividends present for IONS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.